A Novel Canine Model of Portal Vein Stenosis Plus Thioacetamide Administration-Induced Cirrhotic Portal Hypertension With Hypersplenism

Cell Biochemistry and Biophysics

Volumn 62, Issue 1, 2012, Pages 245-255

  Lin, Dexin ^a   Wu, Xianbin ^b   Ji, Xiaoke ^b   Zhang, Qiyu ^b   Lin, Yuan Wei ^b   Chen, Wei Jian ^b   Jin, Wangxun ^b   Deng, Liming ^b   Chen, Yunzhi ^b   Chen, Bicheng ^b   Li, Jianmin ^b  

^a Ningde Municipal Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic function; Hypersplenism; Portal hypertension; Portosystemic collateral circulation; Thioacetamide

Indexed keywords

THIOACETAMIDE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; DOG; FIBROSIS; GASTROSCOPY; HEMODYNAMICS; HYPERSPLENISM; MALE; PATHOLOGY; PORTAL HYPERTENSION; PORTAL VEIN; RANDOMIZATION; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANIMALS; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DOGS; FIBROSIS; GASTROSCOPY; HEMODYNAMICS; HYPERSPLENISM; HYPERTENSION, PORTAL; MALE; PORTAL VEIN; RANDOM ALLOCATION; THIOACETAMIDE; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA; CANIS FAMILIARIS;

EID: 84855568929     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9272-7     Document Type: Article

References (33)

1. Stewart, S. F., & Day, C. P. (2003). The management of alcoholic liver disease. Journal of Hepatology, 38(Suppl 1), S2-S13.
2. Abraldes, J. G., Albillos, A., Banares, R., Turnes, J., Gonzalez, R., Garcia-Pagan, J. C., et al. (2009). Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: A randomized controlled trial. Gastroenterology, 136(5), 1651-1658.
3. Lopez-Talavera, J. C., Merrill, W. W., & Groszmann, R. J. (1995). Tumor necrosis factor alpha: A major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology, 108(3), 761-767.
4. Chen, Y., Zhang, Q., Liao, Y., Guo, F., Zhang, Y., Zeng, Q., et al. (2009). A modified canine model of portal hypertension with hypersplenism. Scandinavian Journal of Gastroenterology, 44(4), 478-485.
5. Zhang, R. P., Zhang, W. H., Xue, D. B., & Wei, Y. W. (2004). Morphology of portal hypertension at the early stage of liver damage induced by CCl4: An experimental study with dogs. Zhonghua Yi Xue Za Zhi, 84(13), 1118-1121.
6. Domenicali, M., Caraceni, P., Giannone, F., Baldassarre, M., Lucchetti, G., Quarta, C., et al. (2009). A novel model of CCl4-induced cirrhosis with ascites in the mouse. Journal of Hepatology, 51(6), 991-999.
7. Jenkins, S. A., Grandison, A., Baxter, J. N., Day, D. W., Taylor, I., & Shields, R. (1985). A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. Journal of Hepatology, 1(5), 489-499.
8. Howe, L. M., Boothe, H. W., Jr., Miller, M. W., & Boothe, D. M. (2000). A canine model of multiple portosystemic shunting. Journal of Investigative Surgery, 13(1), 45-57.
9. Rodriguez Olleros, A., Taveras, J. E., & Delanoy, A. A. (1968). Thioacetamide research in dogs. I. Hepatic cirrhosis. Scandinavian Journal of Gastroenterology, 3(1), 65-75.
10. Laleman, W., Vander Elst, I., Zeegers, M., Servaes, R., Libbrecht, L., Roskams, T., et al. (2006). A stable model of cirrhotic portal hypertension in the rat: Thioacetamide revisited. European Journal of Clinical Investigation, 36(4), 242-249.
11. Li, X., Benjamin, I. S., & Alexander, B. (2002). Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. Journal of Hepatology, 36(4), 488-493.
12. Baddeley, R. M., & Fejfar, J. (1969). A composite canine model of cirrhosis. Annals of Surgery, 169(4), 603-609.
13. Sikuler, E., Kravetz, D., & Groszmann, R. J. (1985). Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. American Journal of Physiology, 248(6 Pt 1), G618-G625.
14. Dashti, H., Jeppsson, B., Hagerstrand, I., Hultberg, B., Srinivas, U., Abdulla, M., et al. (1989). Thioacetamide- and carbon tetrachloride-induced liver cirrhosis. European Surgical Research, 21(2), 83-91.
15. Zimmermann, T., Muller, A., Machnik, G., Franke, H., Schubert, H., & Dargel, R. (1987). Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje: WIST rats. Zeitschrift für Versuchstierkunde, 30(5-6), 165-180.
16. Chojkier, M., & Groszmann, R. J. (1981). Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. American Journal of Physiology, 240(5), G371-G375.
17. Sajjad, S., Garcia, M., Malik, A., & van Thiel, D. H. (2008). An assessment of the accuracy of hepatic and splenic size based upon a clinician's physical examination, a radiologist's impression and the actual liver and spleen volumes calculated by CT scanning. Digestive Diseases and Sciences, 53(7), 1946-1950.
18. Groszmann, R. J., Glickman, M., Blei, A. T., Storer, E., & Conn, H. O. (1979). Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology, 76(2), 253-258.
19. Li, X., Benjamin, I. S., Naftalin, R., & Alexander, B. (2003). Location and function of intrahepatic shunts in anaesthetised rats. Gut, 52(9), 1339-1346.
20. Burgener, F. A., & Fischer, H. W. (1979). Biliary excretion of iodipamide and iodoxamate in dogs with hepatic dysfunction induced by oral administration of dimethylnitrosamine. Investigative Radiology, 14(6), 502-507.
21. Wanless, I. R., Wong, F., Blendis, L. M., Greig, P., Heathcote, E. J., & Levy, G. (1995). Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension. Hepatology, 21(5), 1238-1247.
22. Hou, P. C., & McFadzean, A. J. (1965). Thrombosis and intimal thickening in the portal system in cirrhosis of the liver. Journal of Pathology and Bacteriology, 89, 473-480.
23. Belli, L., Romani, F., Sansalone, C. V., Aseni, P., & Rondinara, G. (1986). Portal thrombosis in cirrhotics. A retrospective analysis. Annals of Surgery, 203(3), 286-291.
24. Onori, P., Morini, S., Franchitto, A., Sferra, R., Alvaro, D., & Gaudio, E. (2000). Hepatic microvascular features in experimental cirrhosis: A structural and morphometrical study in CCl4-treated rats. Journal of Hepatology, 33(4), 555-563.
25. Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R., et al. (2002). Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology, 35(5), 1010-1021.
26. Kim, P. K., Vallabhaneni, R., Zuckerbraun, B. S., McCloskey, C., Vodovotz, Y., & Billiar, T. R. (2005). Hypoxia renders hepatocytes susceptible to cell death by nitric oxide. Cellular and Molecular Biology (Noisy-le-grand), 51(3), 329-335.
27. Rekha, R. D., Amali, A. A., Her, G. M., Yeh, Y. H., Gong, H. Y., Hu, S. Y., et al. (2008). Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio. Toxicology, 243(1-2), 11-22.
28. Chilakapati, J., Korrapati, M. C., Hill, R. A., Warbritton, A., Latendresse, J. R., & Mehendale, H. M. (2007). Toxicokinetics and toxicity of thioacetamide sulfoxide: A metabolite of thioacetamide. Toxicology, 230(2-3), 105-116.
29. Dieguez, B., Aller, M. A., Nava, M. P., Palma, M. D., Arias, J. L., Lopez, L., et al. (2002). Chronic portal hypertension in the rat by triple-portal stenosing ligation. Journal of Investigative Surgery, 15(6), 329-336.
30. Alwmark, A., Bengmark, S., Gullstrand, P., Joelsson, B., Lunderquist, A., & Owman, T. (1982). Evaluation of splenic embolization in patients with portal hypertension and hypersplenism. Annals of Surgery, 196(5), 518-524.
31. Peck-Radosavljevic, M. (2001). Hypersplenism. European Journal of Gastroenterology and Hepatology, 13(4), 317-323.
32. Sahin, M., Tekin, S., Aksoy, F., Vatansev, H., Seker, M., Avunduk, M. C., et al. (2000). The effects of splenic artery ligation in an experimental model of secondary hypersplenism. Journal of the Royal College of Surgeons of Edinburgh, 45(3), 148-152.
33. Shoda, J., Oda, K., Suzuki, H., Sugiyama, Y., Ito, K., Cohen, D. E., et al. (2001). Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi. Hepatology, 33(5), 1194-1205.